Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACH-126,443 vs Continued Lamivudine in HIV
NCT00040157Phase 2Terminated
- Sponsor
- Alexion Pharmaceuticals
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elvucitabine in human immunodeficiency virus infection (HIV), sponsored by Alexion Pharmaceuticals. Status: terminated.
02
Drugs
elvucitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00040157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040157.